M. Usiak

1.8k total citations
14 papers, 1.6k citations indexed

About

M. Usiak is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, M. Usiak has authored 14 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 7 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in M. Usiak's work include Alzheimer's disease research and treatments (9 papers), Prion Diseases and Protein Misfolding (5 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers). M. Usiak is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Prion Diseases and Protein Misfolding (5 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers). M. Usiak collaborates with scholars based in United States and Japan. M. Usiak's co-authors include Steven G. Younkin, Todd E. Golde, Linda H. Younkin, Steven Estus, Mark L. Cohen, Mark R. Palmert, Barry Greenberg, Tatsuhide Kunishita, David E. Lowery and Takeshi Tabira and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

M. Usiak

14 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Usiak United States	13	1.3k	1.0k	332	287	198	14	1.6k
Lawrence M. Refolo United States	10	1.3k 1.0×	757 0.7×	398 1.2×	419 1.5×	251 1.3×	13	1.6k
Camilla Nilsberth Sweden	15	1.2k 0.9×	861 0.8×	324 1.0×	218 0.8×	200 1.0×	22	1.6k
Erene Mina United States	6	1.2k 0.9×	705 0.7×	316 1.0×	413 1.4×	206 1.0×	8	1.6k
Colin L. Masters Australia	14	1.2k 0.9×	850 0.8×	317 1.0×	279 1.0×	212 1.1×	16	1.5k
Luisa Onstead United States	13	1.1k 0.8×	500 0.5×	333 1.0×	249 0.9×	207 1.0×	14	1.3k
G. M. Cole United States	12	849 0.7×	553 0.5×	209 0.6×	207 0.7×	104 0.5×	17	1.2k
Charlotte Forsell Sweden	18	1.3k 1.0×	882 0.8×	280 0.8×	226 0.8×	205 1.0×	35	1.7k
Charlotte Stenh Sweden	4	958 0.7×	629 0.6×	222 0.7×	141 0.5×	207 1.0×	4	1.1k
Annelies Vandersteen Belgium	7	1.1k 0.9×	619 0.6×	285 0.9×	211 0.7×	258 1.3×	8	1.3k
Vicki Betts Ireland	10	933 0.7×	583 0.6×	281 0.8×	286 1.0×	188 0.9×	11	1.3k

Countries citing papers authored by M. Usiak

Since Specialization

Citations

This map shows the geographic impact of M. Usiak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Usiak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Usiak more than expected).

Fields of papers citing papers by M. Usiak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Usiak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Usiak. The network helps show where M. Usiak may publish in the future.

Co-authorship network of co-authors of M. Usiak

This figure shows the co-authorship network connecting the top 25 collaborators of M. Usiak. A scholar is included among the top collaborators of M. Usiak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Usiak. M. Usiak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Usiak, M. & Lynn T. Landmesser. (1999). Neuromuscular Activity Blockade Induced by Muscimol andd-Tubocurarine Differentially Affects the Survival of Embryonic Chick Motoneurons. Journal of Neuroscience. 19(18). 7925–7939. 26 indexed citations

Morgan, Philip G., M. Usiak, & Margaret M. Sedensky. (1996). Genetic Differences Affecting the Potency of Stereoisomers of Isoflurane. Anesthesiology. 85(2). 385–392. 17 indexed citations

Tabaton, Massimo, M.G. Nunzi, Rui Xue, et al.. (1994). Soluble Amyloid β-Protein Is a Marker of Alzheimer Amyloid in Brain But Not in Cerebrospinal Fluid. Biochemical and Biophysical Research Communications. 200(3). 1598–1603. 119 indexed citations

Palmert, Mark R., M. Usiak, Rong Wang, et al.. (1992). Alzheimer's disease and control brain contain soluble derivatives of the amyloid protein precursor that end within the .beta. amyloid protein region. Biochemistry. 31(44). 10936–10940. 22 indexed citations

Estus, Steven, Todd E. Golde, Tatsuhide Kunishita, et al.. (1992). Potentially Amyloidogenic, Carboxyl-Terminal Derivatives of the Amyloid Protein Precursor. Science. 255(5045). 726–728. 366 indexed citations

Golde, Todd E., Steven Estus, M. Usiak, Linda H. Younkin, & Steven G. Younkin. (1990). Expression of β amyloid protein precursor mRNAs: Recognition of a novel alternatively spliced form and quantitation in alzheimer's disease using PCR. Neuron. 4(2). 253–267. 366 indexed citations

Palmert, Mark R., M. Usiak, Richard Mayeux, et al.. (1990). Soluble derivatives of the β amyloid protein precursor in cerebrospinal fluid. Neurology. 40(7). 1028–1028. 94 indexed citations

Palmert, Mark R., Sandra L. Siedlak, Marcia B. Podlisny, et al.. (1989). Soluble derivatives of the β amyloid protein precursor of Alzheimer's disease are labeled by antisera to the β amyloid protein. Biochemical and Biophysical Research Communications. 165(1). 182–188. 72 indexed citations

Palmert, Mark R., Todd E. Golde, Mark L. Cohen, et al.. (1988). Amyloid Protein Precursor Messenger RNAs: Differential Expression in Alzheimer's Disease. Science. 241(4869). 1080–1084. 217 indexed citations

10.

Cohen, Mark L., Todd E. Golde, M. Usiak, Linda H. Younkin, & Steven G. Younkin. (1988). In situ hybridization of nucleus basalis neurons shows increased beta-amyloid mRNA in Alzheimer disease.. Proceedings of the National Academy of Sciences. 85(4). 1227–1231. 160 indexed citations

11.

Cohen, Melvin L., Todd E. Golde, M. Usiak, Linda H. Younkin, & Steven G. Younkin. (1988). In situ hybridization of nucleus basalis neurons shows increased β-amyloid mRNA in Alzheimerʼs disease. Alzheimer Disease & Associated Disorders. 2(4). 383–383. 15 indexed citations

12.

Younkin, Linda H., Gabrielle A. Lockett, M. Usiak, Samuel Younkin, & Uros Roessmann. (1986). MOLECULAR FORMS OF ACETYLCHOLINESTERASE IN ALZHEIMERʼS DISEASE. Journal of Neuropathology & Experimental Neurology. 45(3). 377–377. 29 indexed citations

13.

Younkin, Samuel, et al.. (1986). MORPHOMETRY OF CHOLINERGIC NEURONS IN ALZHEIMERʼS DISEASE. Journal of Neuropathology & Experimental Neurology. 45(3). 341–341. 2 indexed citations

14.

Usiak, M., et al.. (1986). Assembly of monomeric acetylcholinesterase into tetrameric and asymmetric forms.. Journal of Biological Chemistry. 261(3). 1201–1207. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact